Topic summary

Revisiting: Language barriers in accessing a prescription abroad

Access › International EMA telehealth personal import MHRA NHS

This is a generated summary. It shows the 9 most-liked posts from a topic of 149, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

l.oseiTL219 Dec 2025#18

endo_fellow_rk, post #7: Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are on the packaging. That is the version I use. It may not be the version that is correct. Go to post

Taking post #17 at face value and following it one step further.

Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page.

Scoping that to what I have actually seen rather than what I have read.

28 likes in reply to #7 7mo

v.okonkwoTL220 Dec 2025#19

Language matters for finding primary sources. The authoritative document is usually not in English and the translation usually is not authoritative.

I am confident about the direction and much less about the magnitude.

27 likes 7mo

s.balogunTL223 Dec 2025#22

Post #20 put the caveat in the right place and I want to underline it.

Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not eliminate) risk.

Take the reasoning and check the arithmetic; I do not always get it right.

33 likes 7mo

t.verhoevenTL23 Jan 2026#38

Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when in doubt.

Someone should write this up properly, and it should probably not be me.

31 likes 7mo

k.redgraveTL2Member17 Jan 2026#60

l.salinas, post #2: Language matters for finding primary sources. The authoritative document is usually not in English and the translation usually is not authoritative. I would be glad to be shown a cleaner way of putting this. Go to post

Right — I had this wrong and I am glad to have read it before it mattered.

27 likes in reply to #2 6mo

c.grimaldiTL224 Jan 2026#71

I had written a reply contradicting post #67 and deleted it. Here is what survived.

What I would tell a new member reading about Language barriers in accessing for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.

28 likes 6mo

i.norgaardTL212 Feb 2026#105

Worth separating two things that post #102 runs together.

Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.

32 likes 5mo

KLindqvistTL4 Moderator21 Feb 2026#122

On Language barriers in accessing I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get heated.

30 likes 5mo

integrator_draftTL3Regular1 Mar 2026#138

Distinguishing three things in the Language barriers in accessing discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that gets attached to both.

32 likes 5mo

Read the full topic (149 posts)

This topic was referenced in

Personal import allowances, comparedAccess › International · 9 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
Cross-border purchase within the EU: the actual rules Access › International MHRA EMA telehealth NHS Solved Cross-border purchase within the EU: the actual rules Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers on cross-border…	+6	10	41k	11mo
What changed in 2026, by region — does this still hold? Access › International personal import MHRA EMA telehealth Solved What changed in 2026, by region — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in…	+20	25	50k	1d
[2026 update] Travelling with an injectable: documentation and practicalities Access › International telehealth EMA MHRA NHS Travelling with an injectable: documentation and practicalities Writing it up because I had to work it out twice and would rather nobody else did. Dated regional question, February 2026, because everything in…	+107	111	12k	1d
[2026 update] Availability by country, dated, with primary sources Access › International MHRA NHS telehealth personal import On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…	+40	45	14k	4mo
Availability by country, dated, with primary sources Access › International EMA MHRA telehealth personal import On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…	+72	81	6.9k	8mo

Related topics — sharing the tags EMA, telehealth, personal import

Topic	Participants	Replies	Views	Activity
NHS criteria and how they are applied in practice Regional › UK & Ireland NHS cost per milligram personal import MHRA NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. I was wrong about NHS criteria in a thread last spring and I would like to correct it…	+37	42	31k	2d
Coming back to: Preparing for an appointment: one page, three questions Clinical › Prescriber conversations prior authorisation type 2 diabetes telehealth Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. A question about how to describe something to a clinician rather…	+139	151	47k	18mo
Reimbursement variation across member states Regional › European Union EMA personal import cost per milligram Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. Asking about reimbursement variation across member states directly, because I…	+7	11	39k	3mo
Labelling requirements for research chemicals — the long version Sourcing › Regulatory MHRA research use only compounding personal import Posting this under the heading it deserves: Labelling requirements for research chemicals — the long version Everything below is what sits behind that. A narrow question about Labelling requirements for…		2	1.8k	2mo
[2026 update] What a good consultation looks like from the other side Clinical › Prescriber conversations beginner friendly type 2 diabetes telehealth The question in the title: What a good consultation looks like from the other side I will give what I have already checked below so nobody repeats it. Good consultation: what I expected, what I found, and the…	+32	36	13k	1mo